Share market update: 49 stocks hit 52-week highs on NSEOverall, 34 shares were trading in green in Nifty50 index, while 16 were trading in red in the afternoon trade.
Share market update: 61 stocks hit 52-week highs on NSEOverall, 33 shares were trading in green in Nifty50 index, while 17 were trading in red.
Share market update: 14 stocks hit 52-week highs on NSEBayer Cropsc., Alkyl Amines and Coromandel Int. hit their fresh 52-week high during the day.
Share market update: 40 stocks hit 52-week highs on NSEOverall, 34 shares were trading in the green in Nifty50 index, while 16 were trading in the red.
Target price upside for these stocks puts them in playStocks have seen a sharp increase in their target price in the last 30 days.
Top stocks in focus on 06 February 2018Here is a list of top stocks that are likely to be in focus in today's trading session:
How this $66 billion deal turned ‘oracle’ Warren Buffett into an arbitragerWe don't know for sure if it was Buffett himself or one of his stock-picking deputies who made the investment. Either way, he no doubt gave...
Vijay Mallya on three-month watch at Bayer CropScienceVijay Mallya assured the board that he would settle dues with the banks and denied allegations of money laundering.
Nexavar Licence Case: SC dismisses Bayer’s appeal against HC decisionBombay HC in July refused to revoke a compulsory licence issued to India’s Natco Pharma to sell a version of the German drug major’s kidney...
BSE midcap index hits all-time highThe gains in the BSE midcap index were led by HMT. The which surged over 15% in intraday trade. Pipavav Defence gained 10%.
Indra Nooyi-headed Pepsi-Co backs India's much-disputed Intellectual Property RightsIndra Nooyi-headed Pepsi-Co has backed India’s regime of intellectual property rights, it said in comments to the US Trade Representative.
- Intellectual board upholds CL to Natco for cancer drug
The IPAB has upheld the compulsory licence issued to Natco Pharma for production and marketing of generic version of cancer drug Nexavar.
ET 500: Key factors that sets apart some companies which improved cash flows consistentlyThere are 24 cos in the ET 500 list which have shown a consistent growth in net profits.
- Bayer Corp poised for target of Rs 1000-1200: Ventura
Bharat Gala, senior technical analyst, Ventura Securities is of the view that Bayer Corp poised for target of Rs 1000-1200.
- See a price target of 925-950 for Bayer Corp.: Gaurang Shah
Gaurang Shah, Asst VP, Geojit BNP Paribas Financial Services in a chat with ET Now gives his perspective on Bayer Corp.
- Ambuja Realty to set up three IT parks in Kolkata
Ambuja Realty plans to invest over Rs 300 crore to set up three business parks in the city.
- EU slaps fines on 5 chemical giants
European Union regulators slapped five companies, including DuPont and Dow Chemical, with $358 million in fines on Wednesday for fixing the...